N-Hydroxy-4-methylbenzimidamide

Catalog No.: 
ACUHXP082
CAS No.: 
19227-13-5
Molecular Formula: 
C8H10N2O
Molecular Weight: 
150.18
N-Hydroxy-4-methylbenzimidamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$215.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Hydroxy-4-methylbenzimidamide
IUPAC Name(E)-N'-hydroxy-4-methylbenzimidamide
MDL No.MFCD06411167
Molecular FormulaC8H10N2O
Molecular Weight150.18
SMILESO/N=C(C1=CC=C(C=C1)C)/N
InChI KeyNKJXMLIWSJATEE-UHFFFAOYSA-N
Synonym4-Methylbenzamide oxime | 19227-13-5 | 4-Methylbenzamidoxime | N'-Hydroxy-4-methylbenzenecarboximidamide | p-Toluamidoxime | Benzenecarboximidamide, N-hydroxy-4-methyl- | (Z)-N'-hydroxy-4-methylbenzimidamide | p-Tolamidoxime | CHEMBL1630583 | N-hydroxy-4-methylbenzimidamid
CAS No.19227-13-5
PubChem CID5493168

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACUHXP082 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTECN240 route compound structure diagram
    ACTECN240619-55-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUHXP082 route product structure diagram
    ACUHXP08219227-13-5In Stock
Inquiry

2. ACUHXP082 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUHXP082 route product structure diagram
    ACUHXP08219227-13-5In Stock
Inquiry

3. ACUHXP082 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUHXP082 route product structure diagram
    ACUHXP08219227-13-5In Stock
Inquiry

Comments (0)